A phase I multiple ascending dose (SAD) trial of SAGE 718 in healthy volunteers.

Next Previous
Trial Profile

A phase I multiple ascending dose (SAD) trial of SAGE 718 in healthy volunteers.

Planning
Phase of Trial: Phase I

Latest Information Update: 08 Jan 2018

At a glance

  • Drugs SAGE 718
  • Indications Smith-Lemli-Opitz syndrome
  • Focus Adverse reactions

    • Most Recent Events

    • 08 Jan 2018 According to a Sage Therapeutics media release, initiation of this multiple ascending dose study is anticipated in 1H 2018.
    • 08 Nov 2017 New trial record
    • 02 Nov 2017 According to a Sage Therapeutics media release, data readout from this trial is epxected in the second half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top